"Revolutionary Tumor-Freezing Technology Offers Minimally Invasive Breast Cancer Treatment"
TL;DR Summary
IceCure Medical Ltd. is set to submit results from a cryoablation study to the FDA, potentially offering a minimally invasive alternative to surgery for early-stage breast cancer. The study showed positive topline results, with 96.39% of patients being local recurrence-free after treatment with ProSense®. If approved, this technology could revolutionize the treatment of early-stage breast cancer, providing a safer and more effective option than traditional lumpectomy procedures.
Topics:health#breast-cancer#cryoablation#fda#health#icecure-medical-ltd#minimally-invasive-treatment
- Game-Changing Tumor Freezing Technology Has The Potential To Offer Women First-Ever Minimally Invasive Al Benzinga
- This alternative to surgery may be the next frontier in breast cancer treatment New York Post
- Breast cancer patients can now remove their tumors with ice instead of surgery upworthyscience.com
- Why The Less Invasive Breast Cancer Treatment 'Freezing' Is A Game-Changer For Patients | TheHea TheHealthSite
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
4 min
vs 5 min read
Condensed
92%
874 → 67 words
Want the full story? Read the original article
Read on Benzinga